{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:05:31Z","timestamp":1793815531555,"version":"4.6.1"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/INF\/22\/SP45078\/2022"],"award-info":[{"award-number":["BT\/INF\/22\/SP45078\/2022"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12035-025-05137-4","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:41:09Z","timestamp":1749534069000},"page":"13182-13209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Intra-nasal Delivery of Quercetin-Loaded Nanostructured Lipid Carriers (NLCs) in the Management of Alzheimer\u2019s Disease: Formulation, In Vitro and In Vivo assessment"],"prefix":"10.1007","volume":"62","author":[{"given":"Bibhanwita","family":"Satpathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar Kanti","family":"Rajwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet Kumar","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh Kumar","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitu","family":"Halder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Mahanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Manoharadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameel","family":"Al-Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramanian","family":"Palanisamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswakanth","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutam","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutam","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"5137_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K et al (2018) NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 14:535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimer\u2019s Dementia"},{"key":"5137_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.14283\/jpad.2023.61","volume":"11","author":"KL Lanct\u00f4t","year":"2024","unstructured":"Lanct\u00f4t KL, Hahn-Pedersen JH, Eichinger CS et al (2024) Burden of illness in people with Alzheimer\u2019s disease: a systematic review of epidemiology comorbidities and mortality. J Prev Alzheimer\u2019s Dis 11:97\u2013107. https:\/\/doi.org\/10.14283\/jpad.2023.61","journal-title":"J Prev Alzheimer\u2019s Dis"},{"key":"5137_CR3","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules 25:5789. https:\/\/doi.org\/10.3390\/molecules25245789","journal-title":"Molecules"},{"key":"5137_CR4","doi-asserted-by":"publisher","unstructured":"Kumar A, Singh A, Ekavali (2015) A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacological Reports 67:195\u2013203. https:\/\/doi.org\/10.1016\/j.pharep.2014.09.004","DOI":"10.1016\/j.pharep.2014.09.004"},{"key":"5137_CR5","doi-asserted-by":"publisher","first-page":"119990","DOI":"10.1016\/j.lfs.2021.119990","volume":"285","author":"M Raju","year":"2021","unstructured":"Raju M, Kunde SS, Auti ST et al (2021) Berberine loaded nanostructured lipid carrier for Alzheimer\u2019s disease: design, statistical optimization and enhanced in vivo performance. Life Sci 285:119990. https:\/\/doi.org\/10.1016\/j.lfs.2021.119990","journal-title":"Life Sci"},{"key":"5137_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.brainresbull.2019.01.004","volume":"146","author":"Y Madav","year":"2019","unstructured":"Madav Y, Wairkar S, Prabhakar B (2019) Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer\u2019s disease. Brain Res Bull 146:171\u2013184. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.01.004","journal-title":"Brain Res Bull"},{"key":"5137_CR7","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1210\/er.2007-0034","volume":"29","author":"CT Kodl","year":"2008","unstructured":"Kodl CT, Seaquist ER (2008) Cognitive dysfunction and diabetes mellitus. Endocr Rev 29:494\u2013511. https:\/\/doi.org\/10.1210\/er.2007-0034","journal-title":"Endocr Rev"},{"key":"5137_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11892-016-0775-x","volume":"16","author":"LA Zilliox","year":"2016","unstructured":"Zilliox LA, Chadrasekaran K, Kwan JY, Russell JW (2016) Diabetes and cognitive impairment. Curr Diab Rep 16:87. https:\/\/doi.org\/10.1007\/s11892-016-0775-x","journal-title":"Curr Diab Rep"},{"key":"5137_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/biom10010059","volume":"10","author":"H Khan","year":"2019","unstructured":"Khan H, Ullah H, Aschner M et al (2019) Neuroprotective effects of quercetin in Alzheimer\u2019s disease. Biomolecules 10:59. https:\/\/doi.org\/10.3390\/biom10010059","journal-title":"Biomolecules"},{"key":"5137_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/ana.23594","volume":"72","author":"EE Devore","year":"2012","unstructured":"Devore EE, Kang JH, Breteler MMB, Grodstein F (2012) Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann Neurol 72:135\u2013143. https:\/\/doi.org\/10.1002\/ana.23594","journal-title":"Ann Neurol"},{"key":"5137_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3945\/an.114.007500","volume":"6","author":"I Solanki","year":"2015","unstructured":"Solanki I, Parihar P, Mansuri ML, Parihar MS (2015) Flavonoid-based therapies in the early management of neurodegenerative diseases. Adv Nutr 6:64\u201372. https:\/\/doi.org\/10.3945\/an.114.007500","journal-title":"Adv Nutr"},{"key":"5137_CR12","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3390\/brainsci13091258","volume":"13","author":"S Hasan","year":"2023","unstructured":"Hasan S, Khatri N, Rahman ZN et al (2023) Neuroprotective potential of flavonoids in brain disorders. Brain Sci 13:1258. https:\/\/doi.org\/10.3390\/brainsci13091258","journal-title":"Brain Sci"},{"key":"5137_CR13","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.3390\/ijms20123056","volume":"20","author":"P Maher","year":"2019","unstructured":"Maher P (2019) The potential of flavonoids for the treatment of neurodegenerative diseases. IJMS 20:3056. https:\/\/doi.org\/10.3390\/ijms20123056","journal-title":"IJMS"},{"key":"5137_CR14","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3389\/fphar.2019.01417","volume":"10","author":"M Ayaz","year":"2019","unstructured":"Ayaz M, Ullah F, Sadiq A et al (2019) Editorial: natural products-based drugs: potential therapeutics against Alzheimer\u2019s disease and other neurological disorders. Front Pharmacol 10:1417. https:\/\/doi.org\/10.3389\/fphar.2019.01417","journal-title":"Front Pharmacol"},{"key":"5137_CR15","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1017\/S0007114515002950","volume":"114","author":"V Br\u00fcll","year":"2015","unstructured":"Br\u00fcll V, Burak C, Stoffel-Wagner B et al (2015) Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial. Br J Nutr 114:1263\u20131277. https:\/\/doi.org\/10.1017\/S0007114515002950","journal-title":"Br J Nutr"},{"key":"5137_CR16","doi-asserted-by":"publisher","first-page":"101795","DOI":"10.1016\/j.jchemneu.2020.101795","volume":"107","author":"RA Rifaai","year":"2020","unstructured":"Rifaai RA, Mokhemer SA, Saber EA et al (2020) Neuroprotective effect of quercetin nanoparticles: a possible prophylactic and therapeutic role in alzheimer\u2019s disease. J Chem Neuroanat 107:101795. https:\/\/doi.org\/10.1016\/j.jchemneu.2020.101795","journal-title":"J Chem Neuroanat"},{"key":"5137_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.tifs.2021.11.032","volume":"119","author":"K Kandemir","year":"2022","unstructured":"Kandemir K, Tomas M, McClements DJ, Capanoglu E (2022) Recent advances on the improvement of quercetin bioavailability. Trends Food Sci Technol 119:192\u2013200. https:\/\/doi.org\/10.1016\/j.tifs.2021.11.032","journal-title":"Trends Food Sci Technol"},{"key":"5137_CR18","doi-asserted-by":"publisher","first-page":"e09394","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"H Nsairat","year":"2022","unstructured":"Nsairat H, Khater D, Sayed U et al (2022) Liposomes: structure, composition types and clinical applications. Heliyon 8:e09394. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09394","journal-title":"Heliyon"},{"key":"5137_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4103\/0250-474X.57282","volume":"71","author":"S Mukherjee","year":"2009","unstructured":"Mukherjee S, Ray S, Thakur R (2009) Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci 71:349. https:\/\/doi.org\/10.4103\/0250-474X.57282","journal-title":"Indian J Pharm Sci"},{"key":"5137_CR20","doi-asserted-by":"publisher","first-page":"e0286668","DOI":"10.1371\/journal.pone.0286668","volume":"18","author":"M Asad","year":"2023","unstructured":"Asad M, Rasul A, Abbas G et al (2023) Self-emulsifying drug delivery systems: a versatile approach to enhance the oral delivery of BCS class III drug via hydrophobic ion pairing. PLoS ONE 18:e0286668. https:\/\/doi.org\/10.1371\/journal.pone.0286668","journal-title":"PLoS ONE"},{"key":"5137_CR21","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.2174\/1389201025666230830125410","volume":"25","author":"R Goyal","year":"2024","unstructured":"Goyal R, Mittal G, Khurana S et al (2024) Insights on quercetin therapeutic potential for neurodegenerativediseases and its nano-technological perspectives. CPB 25:1132\u20131141. https:\/\/doi.org\/10.2174\/1389201025666230830125410","journal-title":"CPB"},{"key":"5137_CR22","doi-asserted-by":"publisher","first-page":"1519649","DOI":"10.3389\/fphar.2024.1519649","volume":"15","author":"AA Revankar","year":"2025","unstructured":"Revankar AA, Patil AS, Karishetti R et al (2025) Enhanced bioavailability of quercetin-loaded niosomal in situ gel for the management of Parkinson\u2019s disease. Front Pharmacol 15:1519649. https:\/\/doi.org\/10.3389\/fphar.2024.1519649","journal-title":"Front Pharmacol"},{"key":"5137_CR23","doi-asserted-by":"publisher","first-page":"148905","DOI":"10.1016\/j.brainres.2024.148905","volume":"1834","author":"K Kaur","year":"2024","unstructured":"Kaur K, Kulkarni YA, Wairkar S (2024) Exploring the potential of quercetin in Alzheimer\u2019s disease: pharmacodynamics, pharmacokinetics and nanodelivery systems. Brain Res 1834:148905. https:\/\/doi.org\/10.1016\/j.brainres.2024.148905","journal-title":"Brain Res"},{"key":"5137_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.05.005","volume":"394","author":"CY Zhuang","year":"2010","unstructured":"Zhuang CY, Li N, Wang M et al (2010) Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm 394:179\u2013185. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.05.005","journal-title":"Int J Pharm"},{"key":"5137_CR25","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2174\/1381612828666220317141923","volume":"28","author":"X Zhao","year":"2022","unstructured":"Zhao X, Deng Y, Xue X et al (2022) Research progress of quercetin delivery systems. CPD 28:727\u2013742. https:\/\/doi.org\/10.2174\/1381612828666220317141923","journal-title":"CPD"},{"key":"5137_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ijpharm.2013.07.032","volume":"454","author":"W Zhang","year":"2013","unstructured":"Zhang W, Li X, Ye T et al (2013) Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology. Int J Pharm 454:354\u2013366. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.07.032","journal-title":"Int J Pharm"},{"key":"5137_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/pharmaceutics16010058","volume":"16","author":"S Dighe","year":"2023","unstructured":"Dighe S, Jog S, Momin M et al (2023) Intranasal drug delivery by nanotechnology: advances in and challenges for Alzheimer\u2019s disease management. Pharmaceutics 16:58. https:\/\/doi.org\/10.3390\/pharmaceutics16010058","journal-title":"Pharmaceutics"},{"key":"5137_CR28","doi-asserted-by":"publisher","first-page":"979682","DOI":"10.3389\/fphar.2022.979682","volume":"13","author":"A Rajput","year":"2022","unstructured":"Rajput A, Pingale P, Dhapte-Pawar V (2022) Nasal delivery of neurotherapeutics via nanocarriers: facets aspects and prospects. Front Pharmacol 13:979682. https:\/\/doi.org\/10.3389\/fphar.2022.979682","journal-title":"Front Pharmacol"},{"key":"5137_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12951-025-03109-3","volume":"23","author":"YJ Jang","year":"2025","unstructured":"Jang YJ, Kang SJ, Park HS et al (2025) Drug delivery strategies with lipid-based nanoparticles for Alzheimer\u2019s disease treatment. J Nanobiotechnol 23:99. https:\/\/doi.org\/10.1186\/s12951-025-03109-3","journal-title":"J Nanobiotechnol"},{"key":"5137_CR30","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1039\/D4PM00174E","volume":"1","author":"D Sonawane","year":"2024","unstructured":"Sonawane D, Pokharkar V (2024) Nose to brain targeting of the donepezil nanostructured lipid carrier in situ gel: formulation, in vitro, ex vivo, in vivo pharmacokinetic and pharmacodynamic characterization. RSC Pharm 1:820\u2013840. https:\/\/doi.org\/10.1039\/D4PM00174E","journal-title":"RSC Pharm"},{"key":"5137_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B (2019) Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 20:148\u2013160. https:\/\/doi.org\/10.1038\/s41583-019-0132-6","journal-title":"Nat Rev Neurosci"},{"key":"5137_CR32","first-page":"388","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ (2015) Neuroinfl Ammation in Alzheimer\u2019s disease 14:388\u2013405","journal-title":"Neuroinfl Ammation in Alzheimer\u2019s disease"},{"key":"5137_CR33","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrn3820","volume":"15","author":"RP Bazinet","year":"2014","unstructured":"Bazinet RP, Lay\u00e9 S (2014) Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci 15:771\u2013785. https:\/\/doi.org\/10.1038\/nrn3820","journal-title":"Nat Rev Neurosci"},{"key":"5137_CR34","doi-asserted-by":"crossref","unstructured":"Zhao Z, Nelson AR, Betsholtz C (2015) Establishment and dysfunction of the blood-brain barrier. cell 163:1064\u20131078","DOI":"10.1016\/j.cell.2015.10.067"},{"key":"5137_CR35","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3390\/pharmaceutics13081183","volume":"13","author":"MK Satapathy","year":"2021","unstructured":"Satapathy MK, Yen T-L, Jan J-S et al (2021) Solid lipid nanoparticles (SLNs): an advanced drug delivery system targeting brain through BBB. Pharmaceutics 13:1183. https:\/\/doi.org\/10.3390\/pharmaceutics13081183","journal-title":"Pharmaceutics"},{"key":"5137_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001015","author":"JP Higgins","year":"2000","unstructured":"Higgins JP, Flicker L (2000) Lecithin for dementia and cognitive impairment. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD001015","journal-title":"Cochrane Database Syst Rev"},{"key":"5137_CR37","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s11746-003-0844-4","volume":"80","author":"A Judde","year":"2003","unstructured":"Judde A, Villeneuve P, Rossignol-Castera A, Le Guillou A (2003) Antioxidant effect of soy lecithins on vegetable oil stability and their synergism with tocopherols. J Americ Oil Chem Soc 80:1209\u20131215. https:\/\/doi.org\/10.1007\/s11746-003-0844-4","journal-title":"J Americ Oil Chem Soc"},{"key":"5137_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jconrel.2014.03.011","volume":"182","author":"HM Kinnunen","year":"2014","unstructured":"Kinnunen HM, Mrsny RJ (2014) Improving the outcomes of biopharmaceutical delivery via the subcutaneous route by understanding the chemical, physical and physiological properties of the subcutaneous injection site. J Control Release 182:22\u201332. https:\/\/doi.org\/10.1016\/j.jconrel.2014.03.011","journal-title":"J Control Release"},{"key":"5137_CR39","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2147\/IJN.S402447","volume":"18","author":"MK Shehata","year":"2023","unstructured":"Shehata MK, Ismail AA, Kamel MA (2023) Nose to brain delivery of astaxanthin\u2013loaded nanostructured lipid carriers in rat model of Alzheimer\u2019s disease: preparation, in vitro and in vivo evaluation. IJN 18:1631\u20131658. https:\/\/doi.org\/10.2147\/IJN.S402447","journal-title":"IJN"},{"key":"5137_CR40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jconrel.2003.11.012","volume":"95","author":"K Jores","year":"2004","unstructured":"Jores K, Mehnert W, Drechsler M et al (2004) Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release 95:217\u2013227. https:\/\/doi.org\/10.1016\/j.jconrel.2003.11.012","journal-title":"J Control Release"},{"key":"5137_CR41","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.addr.2007.04.013","volume":"59","author":"H Bunjes","year":"2007","unstructured":"Bunjes H, Unruh T (2007) Characterization of lipid nanoparticles by differential scanning calorimetry X-ray and neutron scattering\u2606. Adv Drug Deliv Rev 59:379\u2013402. https:\/\/doi.org\/10.1016\/j.addr.2007.04.013","journal-title":"Adv Drug Deliv Rev"},{"key":"5137_CR42","doi-asserted-by":"publisher","first-page":"105716","DOI":"10.1016\/j.jddst.2024.105716","volume":"96","author":"A Malaiya","year":"2024","unstructured":"Malaiya A, Kenwat R, Mamgain A et al (2024) QbD-based optimization and evaluation of chitosan-adorned nanostructured lipid carriers for nose-to-brain delivery of 17\u03b2-Estradiol in rat model of Alzheimer\u2019s disease. J Drug Delivery Sci Technol 96:105716. https:\/\/doi.org\/10.1016\/j.jddst.2024.105716","journal-title":"J Drug Delivery Sci Technol"},{"key":"5137_CR43","doi-asserted-by":"publisher","first-page":"035010","DOI":"10.1088\/2043-6254\/aba1de","volume":"11","author":"KS Khashan","year":"2020","unstructured":"Khashan KS, Abdulameer FA, Jabir MS et al (2020) Anticancer activity and toxicity of carbon nanoparticles produced by pulsed laser ablation of graphite in water. Adv Nat Sci Nanosci Nanotechnol 11:035010. https:\/\/doi.org\/10.1088\/2043-6254\/aba1de","journal-title":"Adv Nat Sci Nanosci Nanotechnol"},{"key":"5137_CR44","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.apsb.2014.10.005","volume":"4","author":"M Yasir","year":"2014","unstructured":"Yasir M, Sara UVS (2014) Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation. Acta Pharmaceutica Sinica B 4:454\u2013463. https:\/\/doi.org\/10.1016\/j.apsb.2014.10.005","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"5137_CR45","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.ijbiomac.2022.10.010","volume":"222","author":"M Rajkumar","year":"2022","unstructured":"Rajkumar M, Vimala K, Tamiliniyan DD et al (2022) Gelatin\/polyvinyl alcohol loaded magnesium hydroxide nanocomposite attenuates neurotoxicity and oxidative stress in Alzheimer\u2019s disease induced rats. Int J Biol Macromol 222:2122\u20132143. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.10.010","journal-title":"Int J Biol Macromol"},{"key":"5137_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/514095","volume":"2013","author":"H Kumar","year":"2013","unstructured":"Kumar H, Kim I-S, More SV et al (2013) Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson\u2019s disease model. Evid-Based Complement Altern Med 2013:1\u201313. https:\/\/doi.org\/10.1155\/2013\/514095","journal-title":"Evid-Based Complement Altern Med"},{"key":"5137_CR47","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3390\/ijms17111819","volume":"17","author":"I-S Kim","year":"2016","unstructured":"Kim I-S, Ganesan P, Choi D-K (2016) Cx43 mediates resistance against MPP+-induced apoptosis in SH-SY5Y neuroblastoma cells via modulating the mitochondrial apoptosis pathway. IJMS 17:1819. https:\/\/doi.org\/10.3390\/ijms17111819","journal-title":"IJMS"},{"key":"5137_CR48","doi-asserted-by":"publisher","first-page":"e31429","DOI":"10.1016\/j.heliyon.2024.e31429","volume":"10","author":"H Atapour-Mashhad","year":"2024","unstructured":"Atapour-Mashhad H, Tayarani-Najaran Z, Golmohammadzadeh S (2024) Preparation and characterization of novel nanostructured lipid carriers (NLC) and solid lipid nanoparticles (SLN) containing coenzyme Q10 as potent antioxidants and antityrosinase agents. Heliyon 10:e31429. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e31429","journal-title":"Heliyon"},{"key":"5137_CR49","doi-asserted-by":"publisher","first-page":"19393","DOI":"10.1038\/srep19393","volume":"6","author":"M F\u00e1","year":"2016","unstructured":"F\u00e1 M, Puzzo D, Piacentini R et al (2016) Extracellular tau oligomers produce an immediate impairment of LTP and memory. Sci Rep 6:19393. https:\/\/doi.org\/10.1038\/srep19393","journal-title":"Sci Rep"},{"key":"5137_CR50","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/cn300076x","volume":"3","author":"LP Jameson","year":"2012","unstructured":"Jameson LP, Smith NW, Dzyuba SV (2012) Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (A\u03b2) self-assembly. ACS Chem Neurosci 3:807\u2013819. https:\/\/doi.org\/10.1021\/cn300076x","journal-title":"ACS Chem Neurosci"},{"key":"5137_CR51","doi-asserted-by":"publisher","first-page":"105314","DOI":"10.1016\/j.ejps.2020.105314","volume":"148","author":"RGR Pinheiro","year":"2020","unstructured":"Pinheiro RGR, Granja A, Loureiro JA et al (2020) Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer\u2019s disease. Eur J Pharm Sci 148:105314. https:\/\/doi.org\/10.1016\/j.ejps.2020.105314","journal-title":"Eur J Pharm Sci"},{"key":"5137_CR52","doi-asserted-by":"publisher","first-page":"e33077","DOI":"10.1016\/j.heliyon.2024.e33077","volume":"10","author":"Y Chen","year":"2024","unstructured":"Chen Y, Huang X, Chen H, Yi C (2024) An easy-to-perform method for microvessel isolation and primary brain endothelial cell culture to study Alzheimer\u2019s disease. Heliyon 10:e33077. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33077","journal-title":"Heliyon"},{"key":"5137_CR53","doi-asserted-by":"publisher","first-page":"156063","DOI":"10.1016\/j.phymed.2024.156063","volume":"135","author":"Y Lu","year":"2024","unstructured":"Lu Y, Wang Y, Wang Z et al (2024) Ginsenoside Rg2 alleviates astrocyte inflammation and ameliorates the permeability of the Alzheimer\u2019s disease related blood-brain barrier. Phytomedicine 135:156063. https:\/\/doi.org\/10.1016\/j.phymed.2024.156063","journal-title":"Phytomedicine"},{"key":"5137_CR54","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jddst.2018.11.021","volume":"49","author":"A Anand","year":"2019","unstructured":"Anand A, Arya M, Kaithwas G et al (2019) Sucrose stearate as a biosurfactant for development of rivastigmine containing nanostructured lipid carriers and assessment of its activity against dementia in C. elegans model. J Drug Deliv Sci Technol 49:219\u2013226. https:\/\/doi.org\/10.1016\/j.jddst.2018.11.021","journal-title":"J Drug Deliv Sci Technol"},{"key":"5137_CR55","doi-asserted-by":"publisher","first-page":"103145","DOI":"10.1016\/j.jddst.2022.103145","volume":"69","author":"SP Pradhan","year":"2022","unstructured":"Pradhan SP, Sahoo S, Behera A et al (2022) Memory amelioration by hesperidin conjugated gold nanoparticles in diabetes induced cognitive impaired rats. J Drug Deliv Sci Technol 69:103145. https:\/\/doi.org\/10.1016\/j.jddst.2022.103145","journal-title":"J Drug Deliv Sci Technol"},{"key":"5137_CR56","doi-asserted-by":"publisher","first-page":"106393","DOI":"10.1016\/j.jddst.2024.106393","volume":"102","author":"S Dighe","year":"2024","unstructured":"Dighe S, Lonkar S, Jog S et al (2024) Thermosensitive in-situ gel of nifedipine: a strategy to offset cognition impairment in Alzheimer\u2019s disease. J Drug Deliv Sci Technol 102:106393. https:\/\/doi.org\/10.1016\/j.jddst.2024.106393","journal-title":"J Drug Deliv Sci Technol"},{"key":"5137_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04436-6","author":"B Satpathy","year":"2024","unstructured":"Satpathy B, Sa N, Behera A, Sahu PK (2024) Dose-dependent attenuation of the efficacy of Clitoria ternatea by cobalt oxide nanoparticles against diabetes-induced cognitive impairment. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-04436-6","journal-title":"Mol Neurobiol"},{"key":"5137_CR58","doi-asserted-by":"publisher","first-page":"249","DOI":"10.14712\/18059694.2018.99","volume":"47","author":"L Barto\u0161ov\u00e1","year":"2004","unstructured":"Barto\u0161ov\u00e1 L, Kune\u0161ov\u00e1 G, Ku\u010da K, Vachek J (2004) Therapeutic efficacy of different antidotal mixtures against poisoning with GF-agent in mice. Acta Med (Hradec Kralove Czech Repub) 47:249\u2013251. https:\/\/doi.org\/10.14712\/18059694.2018.99","journal-title":"Acta Med (Hradec Kralove Czech Repub)"},{"key":"5137_CR59","doi-asserted-by":"publisher","first-page":"13450","DOI":"10.1021\/acsami.9b02279","volume":"11","author":"S Ranjan Sarker","year":"2019","unstructured":"Ranjan Sarker S, Polash SA, Boath J et al (2019) Functionalization of Elongated tetrahexahedral Au nanoparticles and their antimicrobial activity assay. ACS Appl Mater Interfaces 11:13450\u201313459. https:\/\/doi.org\/10.1021\/acsami.9b02279","journal-title":"ACS Appl Mater Interfaces"},{"key":"5137_CR60","doi-asserted-by":"publisher","first-page":"125218","DOI":"10.1016\/j.talanta.2023.125218","volume":"267","author":"Z Eryaman","year":"2024","unstructured":"Eryaman Z, Hizal J, Y\u0131lmazo\u011flu M et al (2024) The performance of hypochlorous acid modified Ag nanoparticle-based assay in the determination of total antioxidant capacity of Boswellia Serrata and Aronia. Talanta 267:125218. https:\/\/doi.org\/10.1016\/j.talanta.2023.125218","journal-title":"Talanta"},{"key":"5137_CR61","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.18632\/aging.101627","volume":"10","author":"MTM Salissou","year":"2018","unstructured":"Salissou MTM, Mahaman YAR, Zhu F et al (2018) Methanolic extract of Tamarix Gallica attenuates hyperhomocysteinemia induced AD-like pathology and cognitive impairments in rats. Aging 10:3229\u20133248. https:\/\/doi.org\/10.18632\/aging.101627","journal-title":"Aging"},{"key":"5137_CR62","doi-asserted-by":"publisher","first-page":"30748","DOI":"10.1038\/s41598-024-80320-6","volume":"14","author":"A Behera","year":"2024","unstructured":"Behera A, Satpathy B, Sahoo RK, Sahu PK (2024) Amelioration of cognition by hesperidin-conjugated cobalt oxide nanoparticles. Sci Rep 14:30748. https:\/\/doi.org\/10.1038\/s41598-024-80320-6","journal-title":"Sci Rep"},{"key":"5137_CR63","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neurobiolaging.2018.12.019","volume":"76","author":"R Taipa","year":"2019","unstructured":"Taipa R, Das Neves SP, Sousa AL et al (2019) Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer\u2019s disease and their correlation with cognitive decline. Neurobiol Aging 76:125\u2013132. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.12.019","journal-title":"Neurobiol Aging"},{"key":"5137_CR64","doi-asserted-by":"publisher","first-page":"100149","DOI":"10.1016\/j.crphar.2022.100149","volume":"4","author":"V Rani","year":"2023","unstructured":"Rani V, Verma R, Kumar K, Chawla R (2023) Role of pro-inflammatory cytokines in Alzheimer\u2019s disease and neuroprotective effects of pegylated self-assembled nanoscaffolds. Curr Res Pharmacol Drug Discovery 4:100149. https:\/\/doi.org\/10.1016\/j.crphar.2022.100149","journal-title":"Curr Res Pharmacol Drug Discovery"},{"key":"5137_CR65","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.3390\/pharmaceutics15082036","volume":"15","author":"K Manta","year":"2023","unstructured":"Manta K, Papakyriakopoulou P, Nikolidaki A et al (2023) Comparative serum and brain pharmacokinetics of quercetin after oral and nasal administration to rats as lyophilized complexes with \u03b2-cyclodextrin derivatives and their blends with mannitol\/lecithin microparticles. Pharmaceutics 15:2036. https:\/\/doi.org\/10.3390\/pharmaceutics15082036","journal-title":"Pharmaceutics"},{"key":"5137_CR66","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","volume":"281","author":"M Agrawal","year":"2018","unstructured":"Agrawal M, Saraf S, Saraf S et al (2018) Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Control Release 281:139\u2013177. https:\/\/doi.org\/10.1016\/j.jconrel.2018.05.011","journal-title":"J Control Release"},{"key":"5137_CR67","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1590\/0004-282X20150083","volume":"73","author":"B Silva","year":"2015","unstructured":"Silva B, Sousa L, Miranda A et al (2015) Memory deficit associated with increased brain proinflammatory cytokine levels and neurodegeneration in acute ischemic stroke. Arq Neuro-Psiquiatr 73:655\u2013659. https:\/\/doi.org\/10.1590\/0004-282X20150083","journal-title":"Arq Neuro-Psiquiatr"},{"key":"5137_CR68","doi-asserted-by":"publisher","first-page":"106494","DOI":"10.1016\/j.micpath.2023.106494","volume":"186","author":"R Nayak","year":"2024","unstructured":"Nayak R, Halder J, Rajwar TK et al (2024) Design and evaluation of antibacterials crosslinked chitosan nanoparticle as a novel carrier for the delivery of metronidazole to treat bacterial vaginosis. Microb Pathog 186:106494. https:\/\/doi.org\/10.1016\/j.micpath.2023.106494","journal-title":"Microb Pathog"},{"key":"5137_CR69","doi-asserted-by":"publisher","first-page":"7971","DOI":"10.3390\/molecules27227971","volume":"27","author":"Y Liao","year":"2022","unstructured":"Liao Y, Mai X, Wu X et al (2022) Exploring the inhibition of quercetin on acetylcholinesterase by multispectroscopic and in silico approaches and evaluation of its neuroprotective effects on PC12 cells. Molecules 27:7971. https:\/\/doi.org\/10.3390\/molecules27227971","journal-title":"Molecules"},{"key":"5137_CR70","unstructured":"Wang Y, Ji Y, Liu D Identification of common FTIR spectral features and spectral interferences of atmospheric gases. Appl Spectrosc 69:1303\u20131310"},{"key":"5137_CR71","doi-asserted-by":"publisher","first-page":"035001","DOI":"10.1088\/1468-6996\/16\/3\/035001","volume":"16","author":"M Catauro","year":"2015","unstructured":"Catauro M, Papale F, Bollino F et al (2015) Silica\/quercetin sol\u2013gel hybrids as antioxidant dental implant materials. Sci Technol Adv Mater 16:035001. https:\/\/doi.org\/10.1088\/1468-6996\/16\/3\/035001","journal-title":"Sci Technol Adv Mater"},{"key":"5137_CR72","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/foods9020123","volume":"9","author":"Q Wang","year":"2020","unstructured":"Wang Q, Wei H, Deng C et al (2020) Improving stability and accessibility of quercetin in olive oil-in-soy protein isolate\/pectin stabilized O\/W emulsion. Foods 9:123. https:\/\/doi.org\/10.3390\/foods9020123","journal-title":"Foods"},{"key":"5137_CR73","doi-asserted-by":"publisher","first-page":"104555","DOI":"10.1016\/j.jddst.2023.104555","volume":"86","author":"D Jain","year":"2023","unstructured":"Jain D, Hasan N, Zafar S et al (2023) Transferrin functionalized nanostructured lipid carriers for targeting Rivastigmine and Resveratrol to Alzheimer\u2019s disease: synthesis, in vitro characterization and brain uptake analysis. J Drug Deliv Sci Technol 86:104555. https:\/\/doi.org\/10.1016\/j.jddst.2023.104555","journal-title":"J Drug Deliv Sci Technol"},{"key":"5137_CR74","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1039\/D4PM00057A","volume":"1","author":"M Das","year":"2024","unstructured":"Das M, Sarma A, Baruah H, Basak D (2024) Insight into central nervous system targeted nanostructured lipid carriers via the nose to brain pathway. RSC Pharm 1:904\u2013927. https:\/\/doi.org\/10.1039\/D4PM00057A","journal-title":"RSC Pharm"},{"key":"5137_CR75","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/156720109787048230","volume":"6","author":"G Papageorgiou","year":"2009","unstructured":"Papageorgiou G, Papadimitriou S, Karavas E et al (2009) Improvement in chemical and physical stability of fluvastatin drug through hydrogen bonding interactions with different polymer matrices. CDD 6:101\u2013112. https:\/\/doi.org\/10.2174\/156720109787048230","journal-title":"CDD"},{"key":"5137_CR76","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jconrel.2019.02.030","volume":"299","author":"F Caputo","year":"2019","unstructured":"Caputo F, Clogston J, Calzolai L et al (2019) Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity. J Control Release 299:31\u201343. https:\/\/doi.org\/10.1016\/j.jconrel.2019.02.030","journal-title":"J Control Release"},{"key":"5137_CR77","doi-asserted-by":"publisher","first-page":"111838","DOI":"10.1016\/j.colsurfb.2021.111838","volume":"205","author":"S Saini","year":"2021","unstructured":"Saini S, Sharma T, Jain A et al (2021) Systematically designed chitosan-coated solid lipid nanoparticles of ferulic acid for effective management of Alzheimer\u2019s disease: a preclinical evidence. Colloids Surf B 205:111838. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.111838","journal-title":"Colloids Surf B"},{"key":"5137_CR78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12868-020-00579-z","volume":"21","author":"J Miao","year":"2020","unstructured":"Miao J, Jing J, Shao Y, Sun H (2020) MicroRNA-138 promotes neuroblastoma SH-SY5Y cell apoptosis by directly targeting DEK in Alzheimer\u2019s disease cell model. BMC Neurosci 21:33. https:\/\/doi.org\/10.1186\/s12868-020-00579-z","journal-title":"BMC Neurosci"},{"key":"5137_CR79","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/molecules22020277","volume":"22","author":"J Loureiro","year":"2017","unstructured":"Loureiro J, Andrade S, Duarte A et al (2017) Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer\u2019s disease. Molecules 22:277. https:\/\/doi.org\/10.3390\/molecules22020277","journal-title":"Molecules"},{"key":"5137_CR80","doi-asserted-by":"publisher","first-page":"122749","DOI":"10.1016\/j.biomaterials.2024.122749","volume":"312","author":"A Xie","year":"2025","unstructured":"Xie A, Cheng G, Wu J et al (2025) Highly BBB-permeable nanomedicine reverses neuroapoptosis and neuroinflammation to treat Alzheimer\u2019s disease. Biomaterials 312:122749. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122749","journal-title":"Biomaterials"},{"key":"5137_CR81","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41598-023-27665-6","volume":"13","author":"KY Mahmoud","year":"2023","unstructured":"Mahmoud KY, Elhesaisy NA, Rashed AR et al (2023) Exploring the potential of intranasally administered naturally occurring quercetin loaded into polymeric nanocapsules as a novel platform for the treatment of anxiety. Sci Rep 13:510. https:\/\/doi.org\/10.1038\/s41598-023-27665-6","journal-title":"Sci Rep"},{"key":"5137_CR82","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ijpharm.2013.11.049","volume":"461","author":"C Zhang","year":"2014","unstructured":"Zhang C, Chen J, Feng C et al (2014) Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer\u2019s disease. Int J Pharm 461:192\u2013202. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.11.049","journal-title":"Int J Pharm"},{"key":"5137_CR83","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/medicina55040114","volume":"55","author":"F Niazvand","year":"2019","unstructured":"Niazvand F, Orazizadeh M, Khorsandi L et al (2019) Effects of quercetin-loaded nanoparticles on MCF-7 human breast cancer cells. Medicina 55:114. https:\/\/doi.org\/10.3390\/medicina55040114","journal-title":"Medicina"},{"key":"5137_CR84","doi-asserted-by":"publisher","first-page":"e0301355","DOI":"10.1371\/journal.pone.0301355","volume":"19","author":"A-SA-S Newairy","year":"2024","unstructured":"Newairy A-SA-S, Hamaad FA, Wahby MM et al (2024) Neurotherapeutic effects of quercetin-loaded nanoparticles and Biochanin-A extracted from Trifolium alexandrinum on PI3K\/Akt\/GSK-3\u03b2 signaling in the cerebral cortex of male diabetic rats. PLoS ONE 19:e0301355. https:\/\/doi.org\/10.1371\/journal.pone.0301355","journal-title":"PLoS ONE"},{"key":"5137_CR85","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ijpharm.2012.03.042","volume":"430","author":"G Chen-yu","year":"2012","unstructured":"Chen-yu G, Chun-fen Y, Qi-lu L et al (2012) Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int J Pharm 430:292\u2013298. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.03.042","journal-title":"Int J Pharm"},{"key":"5137_CR86","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.foodchem.2016.11.028","volume":"221","author":"J Li","year":"2017","unstructured":"Li J, Lu J, Qiao X, Xu Z (2017) A study on biomimetic immunoassay-capillary electrophoresis method based on molecularly imprinted polymer for determination of trace trichlorfon residue in vegetables. Food Chem 221:1285\u20131290. https:\/\/doi.org\/10.1016\/j.foodchem.2016.11.028","journal-title":"Food Chem"},{"key":"5137_CR87","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.1021\/acs.jpcb.2c02763","volume":"126","author":"A Alghamdi","year":"2022","unstructured":"Alghamdi A, Birch DJS, Vyshemirsky V, Rolinski OJ (2022) Impact of the flavonoid quercetin on \u03b2-amyloid aggregation revealed by intrinsic fluorescence. J Phys Chem B 126:7229\u20137237. https:\/\/doi.org\/10.1021\/acs.jpcb.2c02763","journal-title":"J Phys Chem B"},{"key":"5137_CR88","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/ph17040466","volume":"17","author":"VVN Goli","year":"2024","unstructured":"Goli VVN, Tatineni S, Hani U et al (2024) Pharmacokinetics and pharmacodynamics of a nanostructured lipid carrier co-encapsulating artemether and miRNA for mitigating cerebral malaria. Pharmaceuticals 17:466. https:\/\/doi.org\/10.3390\/ph17040466","journal-title":"Pharmaceuticals"},{"key":"5137_CR89","doi-asserted-by":"publisher","first-page":"7329","DOI":"10.1007\/s12035-023-03539-w","volume":"60","author":"A Behera","year":"2023","unstructured":"Behera A, Pradhan SP, Tejaswani P et al (2023) Ameliorative and neuroprotective effect of core-shell type Se@Au conjugated hesperidin nanoparticles in diabetes-induced cognitive impairment. Mol Neurobiol 60:7329\u20137345. https:\/\/doi.org\/10.1007\/s12035-023-03539-w","journal-title":"Mol Neurobiol"},{"key":"5137_CR90","doi-asserted-by":"publisher","first-page":"102869","DOI":"10.1016\/j.tice.2025.102869","volume":"95","author":"B Satpathy","year":"2025","unstructured":"Satpathy B, Saha I, Halder J et al (2025) In vitro and in silico anti-Alzheimer study of rutin embedded with zinc chloride loaded bovine serum albumin nanoparticles. Tissue Cell 95:102869. https:\/\/doi.org\/10.1016\/j.tice.2025.102869","journal-title":"Tissue Cell"},{"key":"5137_CR91","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1208\/s12249-016-0573-4","volume":"18","author":"A Vijayakumar","year":"2017","unstructured":"Vijayakumar A, Baskaran R, Jang YS et al (2017) Quercetin-loaded solid lipid nanoparticle dispersion with improved physicochemical properties and cellular uptake. AAPS PharmSciTech 18:875\u2013883. https:\/\/doi.org\/10.1208\/s12249-016-0573-4","journal-title":"AAPS PharmSciTech"},{"key":"5137_CR92","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","volume":"18","author":"S Zha","year":"2024","unstructured":"Zha S, Liu H, Li H et al (2024) Functionalized nanomaterials capable of crossing the blood\u2013brain barrier. ACS Nano 18:1820\u20131845. https:\/\/doi.org\/10.1021\/acsnano.3c10674","journal-title":"ACS Nano"},{"key":"5137_CR93","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0731-7085(03)00529-6","volume":"34","author":"T Pralhad","year":"2004","unstructured":"Pralhad T, Rajendrakumar K (2004) Study of freeze-dried quercetin\u2013cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis. J Pharm Biomed Anal 34:333\u2013339. https:\/\/doi.org\/10.1016\/S0731-7085(03)00529-6","journal-title":"J Pharm Biomed Anal"},{"key":"5137_CR94","doi-asserted-by":"crossref","unstructured":"Singh D, Rawat M, Semalty A quercetin-phospholipid complex: an amorphous pharmaceutical system in herbal drug delivery. Current Drug Discovery Technologies 9","DOI":"10.2174\/157016312799304507"},{"key":"5137_CR95","doi-asserted-by":"publisher","first-page":"6630","DOI":"10.3390\/molecules27196630","volume":"27","author":"C Tsioptsias","year":"2022","unstructured":"Tsioptsias C, Tsivintzelis I (2022) On the thermodynamic thermal properties of quercetin and similar pharmaceuticals. Molecules 27:6630. https:\/\/doi.org\/10.3390\/molecules27196630","journal-title":"Molecules"},{"key":"5137_CR96","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.xphs.2019.01.007","volume":"108","author":"H Uchiyama","year":"2019","unstructured":"Uchiyama H, Wada Y, Hatanaka Y et al (2019) Solubility and permeability improvement of quercetin by an interaction between \u03b1-glucosyl stevia nanoaggregates and hydrophilic polymer. J Pharm Sci 108:2033\u20132040. https:\/\/doi.org\/10.1016\/j.xphs.2019.01.007","journal-title":"J Pharm Sci"},{"key":"5137_CR97","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.3390\/pharmaceutics15082078","volume":"15","author":"M L\u00facio","year":"2023","unstructured":"L\u00facio M, Giannino N, Barreira S et al (2023) Nanostructured lipid carriers enriched hydrogels for skin topical administration of quercetin and omega-3 fatty acid. Pharmaceutics 15:2078. https:\/\/doi.org\/10.3390\/pharmaceutics15082078","journal-title":"Pharmaceutics"},{"key":"5137_CR98","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.nano.2015.09.004","volume":"12","author":"A Beloqui","year":"2016","unstructured":"Beloqui A, Solin\u00eds M\u00c1, Rodr\u00edguez-Gasc\u00f3n A et al (2016) Nanostructured lipid carriers: promising drug delivery systems for future clinics. Nanomedicine: Nanotechnology. Biol Med 12:143\u2013161. https:\/\/doi.org\/10.1016\/j.nano.2015.09.004","journal-title":"Biol Med"},{"key":"5137_CR99","doi-asserted-by":"publisher","first-page":"104339","DOI":"10.1016\/j.jddst.2023.104339","volume":"82","author":"AP Najafabadi","year":"2023","unstructured":"Najafabadi AP, Pourmadadi M, Yazdian F et al (2023) pH-sensitive ameliorated quercetin delivery using graphene oxide nanocarriers coated with potential anticancer gelatin-polyvinylpyrrolidone nanoemulsion with bitter almond oil. J Drug Deliv Sci Technol 82:104339. https:\/\/doi.org\/10.1016\/j.jddst.2023.104339","journal-title":"J Drug Deliv Sci Technol"},{"key":"5137_CR100","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ejps.2012.12.005","volume":"48","author":"S Bose","year":"2013","unstructured":"Bose S, Michniak-Kohn B (2013) Preparation and characterization of lipid based nanosystems for topical delivery of quercetin. Eur J Pharm Sci 48:442\u2013452. https:\/\/doi.org\/10.1016\/j.ejps.2012.12.005","journal-title":"Eur J Pharm Sci"},{"key":"5137_CR101","doi-asserted-by":"publisher","unstructured":"Porfiryeva NN, Semina II, Salakhov IA, et al (2021) Mucoadhesive and mucus-penetrating interpolyelectrolyte complexes for nose-to-brain drug delivery. Nanomedicine: Nanotechnol Biol Med 37:102432. https:\/\/doi.org\/10.1016\/j.nano.2021.102432","DOI":"10.1016\/j.nano.2021.102432"},{"key":"5137_CR102","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0928-4931(95)00102-6","volume":"3","author":"YA Shchipunov","year":"1995","unstructured":"Shchipunov YA, Shumilina EV (1995) Lecithin bridging by hydrogen bonds in the organogel. Mater Sci Eng C 3:43\u201350. https:\/\/doi.org\/10.1016\/0928-4931(95)00102-6","journal-title":"Mater Sci Eng C"},{"key":"5137_CR103","doi-asserted-by":"publisher","first-page":"103561","DOI":"10.1016\/j.jddst.2022.103561","volume":"74","author":"KV Jardim","year":"2022","unstructured":"Jardim KV, Siqueira JLN, B\u00e1o SN, Parize AL (2022) In vitro cytotoxic and antioxidant evaluation of quercetin loaded in ionic cross-linked chitosan nanoparticles. J Drug Deliv Sci Technol 74:103561. https:\/\/doi.org\/10.1016\/j.jddst.2022.103561","journal-title":"J Drug Deliv Sci Technol"},{"key":"5137_CR104","doi-asserted-by":"publisher","unstructured":"Reis S, Neves, L\u00facio, et al (2013) Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. IJN 177. https:\/\/doi.org\/10.2147\/IJN.S37840","DOI":"10.2147\/IJN.S37840"},{"key":"5137_CR105","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495\u2013516. https:\/\/doi.org\/10.1080\/01926230701320337","journal-title":"Toxicol Pathol"},{"key":"5137_CR106","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jep.2012.07.005","volume":"143","author":"F Dajas","year":"2012","unstructured":"Dajas F (2012) Life or death: Neuroprotective and anticancer effects of quercetin. J Ethnopharmacol 143:383\u2013396. https:\/\/doi.org\/10.1016\/j.jep.2012.07.005","journal-title":"J Ethnopharmacol"},{"key":"5137_CR107","doi-asserted-by":"publisher","first-page":"114300","DOI":"10.1016\/j.colsurfb.2024.114300","volume":"245","author":"X Guo","year":"2025","unstructured":"Guo X, Zhang B, Chen Y et al (2025) Multifunctional mesoporous nanoselenium delivery of metformin breaks the vicious cycle of neuroinflammation and ROS, promotes microglia regulation and alleviates Alzheimer\u2019s disease. Colloids Surf, B 245:114300. https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114300","journal-title":"Colloids Surf, B"},{"key":"5137_CR108","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.brainresbull.2016.06.005","volume":"133","author":"A Tramutola","year":"2017","unstructured":"Tramutola A, Lanzillotta C, Perluigi M, Butterfield DA (2017) Oxidative stress, protein modification and Alzheimer disease. Brain Res Bull 133:88\u201396. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.06.005","journal-title":"Brain Res Bull"},{"key":"5137_CR109","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3233\/JAD-210735","volume":"84","author":"Q Wang","year":"2021","unstructured":"Wang Q, Dong X, Zhang R, Zhao C (2021) Flavonoids with potential anti-amyloidogenic effects as therapeutic drugs for treating Alzheimer\u2019s disease. JAD 84:505\u2013533. https:\/\/doi.org\/10.3233\/JAD-210735","journal-title":"JAD"},{"key":"5137_CR110","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s11095-024-03790-3","volume":"41","author":"H Zeng","year":"2024","unstructured":"Zeng H, Lu H, Yang J, Hu P (2024) An update on recent drug delivery systems targeting brain diseases via the transnasal pathway. Pharm Res 41:2121\u20132141. https:\/\/doi.org\/10.1007\/s11095-024-03790-3","journal-title":"Pharm Res"},{"key":"5137_CR111","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.3390\/ijms24076328","volume":"24","author":"M-C Chiang","year":"2023","unstructured":"Chiang M-C, Tsai T-Y, Wang C-J (2023) The potential benefits of quercetin for brain health: a review of anti-inflammatory and neuroprotective mechanisms. IJMS 24:6328. https:\/\/doi.org\/10.3390\/ijms24076328","journal-title":"IJMS"},{"key":"5137_CR112","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3390\/antiox11101986","volume":"11","author":"NK Alaqeel","year":"2022","unstructured":"Alaqeel NK, AlSheikh MH, Al-Hariri MT (2022) Quercetin nanoemulsion ameliorates neuronal dysfunction in experimental Alzheimer\u2019s disease model. Antioxidants 11:1986. https:\/\/doi.org\/10.3390\/antiox11101986","journal-title":"Antioxidants"},{"key":"5137_CR113","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1615\/IntJMedMushrooms.2019031508","volume":"21","author":"A Kaur","year":"2019","unstructured":"Kaur A, Randhawa K, Singh V, Shri R (2019) Bioactivity-guided isolation of acetylcholinesterase inhibitor from Ganoderma mediosinense (agaricomycetes). Int J Med Mushrooms 21:755\u2013763. https:\/\/doi.org\/10.1615\/IntJMedMushrooms.2019031508","journal-title":"Int J Med Mushrooms"},{"key":"5137_CR114","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3233\/JAD-200473","volume":"76","author":"E Solis","year":"2020","unstructured":"Solis E, Hascup KN, Hascup ER (2020) Alzheimer\u2019s disease: the link between amyloid-\u03b2 and neurovascular dysfunction. JAD 76:1179\u20131198. https:\/\/doi.org\/10.3233\/JAD-200473","journal-title":"JAD"},{"key":"5137_CR115","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/brainsci11040466","volume":"11","author":"M Lanza","year":"2021","unstructured":"Lanza M, Casili G, Campolo M et al (2021) Immunomodulatory effect of microglia-released cytokines in gliomas. Brain Sci 11:466. https:\/\/doi.org\/10.3390\/brainsci11040466","journal-title":"Brain Sci"},{"key":"5137_CR116","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3389\/fcell.2019.00313","volume":"7","author":"YJ Jung","year":"2019","unstructured":"Jung YJ, Tweedie D, Scerba MT, Greig NH (2019) Neuroinflammation as a factor of neurodegenerative disease: thalidomide analogs as treatments. Front Cell Dev Biol 7:313. https:\/\/doi.org\/10.3389\/fcell.2019.00313","journal-title":"Front Cell Dev Biol"},{"key":"5137_CR117","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12974-019-1490-8","volume":"16","author":"O Sheppard","year":"2019","unstructured":"Sheppard O, Coleman MP, Durrant CS (2019) Lipopolysaccharide-induced neuroinflammation induces presynaptic disruption through a direct action on brain tissue involving microglia-derived interleukin 1 beta. J Neuroinflammation 16:106. https:\/\/doi.org\/10.1186\/s12974-019-1490-8","journal-title":"J Neuroinflammation"},{"key":"5137_CR118","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3390\/antiox10101628","volume":"10","author":"M Jazvin\u0161\u0107ak Jembrek","year":"2021","unstructured":"Jazvin\u0161\u0107ak Jembrek M, Or\u0161oli\u0107 N, Mandi\u0107 L et al (2021) Anti-oxidative, anti-inflammatory and anti-apoptotic effects of flavonols: targeting Nrf2, NF-\u03baB and p53 pathways in neurodegeneration. Antioxidants 10:1628. https:\/\/doi.org\/10.3390\/antiox10101628","journal-title":"Antioxidants"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05137-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:33:44Z","timestamp":1757745224000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05137-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":118,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5137"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05137-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}